Oncology Specialties, P.C.

Huntsville, AL Health careNAICS 621111

Self-funded health planPlan year 2025Renews January
596Participants-15% vs. prior year
$1.4MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#13 of 15Health care in ALBy participants

Overview

Oncology Specialties, P.C. sponsors a self-funded health plan that covered 596 participants in plan year 2025, down 15% from the prior year. The plan year starts in January.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
596 · prior year 702
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Oncology Specialties, P.C. Employee Benefits Plan, plan 502 (596 participants)
Medical

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$1.4M/ year

Estimated prescription spend: 596 participants × $2,371 national average per member. Usually higher once dependents are counted.

$37K–$91K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$11K–$27K
Lower-cost therapeutic alternatives$16K–$33K
Generic pricing vs. actual cost$7K–$20K
PBM contract terms$4K–$11K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Oncology Specialties, P.C.
Sponsor EIN
63-0897317
Plan number
502
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 63-0897317 in the Department of Labor's EFAST2 Form 5500 search.

About this data

Source: Oncology Specialties, P.C.'s Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Oncology Specialties, P.C..

Request a correction · Methodology